SW48 cell lysate on PVDF membrane was treated with normal sera and sera from patients with Stages I-IV CRC. As it was mentioned, immune blotting results were analyzed by ImageJ software and 10 bands from each lane were selected for further evaluating of the density. The molecular weights of these bands were selected between size ranges of 25-110 kDa. Results from these analyses are shown in Figure 4 . Among 10 reactive bands obtained from SW48 cell line, 4 bands (bands 2, 4, 6 and 8) in patients had a significantly higher intensity (P < 0.001) than normal ones and the most intensity was related to sera from patients with Stage III CRC. Furthermore, the intensity of bands 6 and 8 in Stage IV of CRC patients were significantly (P < 0.001) elevated in relation to normal sera. Among patients with Stage II of CRC only the intensity of band 8 was significantly (P < 0.001) higher than band 8 from normal sera and the other bands, intensities were not significantly different. Also, no significant difference was detected between the bands obtained from SW48 cell lysate and sera of patients with Stage I compared with normal serum.
Immune reactivity pattern of patients and normal sera with SW1116 cell lysate
Immune reactivity of SW1116 cell lysate with different CRC patients' sera (Stages II-IV) revealed that 5 from 10 bands had different intensity in relation to normal controls' sera [ Figure 5 ]. There was not any immune reactivity difference between normal and Stage I CRC patients' sera. Bands 2, 3 and 7 related to Stage II patients' sera in reaction with SW1116 cell line lysate had a significantly higher (P < 0.01) intensity in relation to normal controls reactions. Moreover, B and 4 in Stage III and 8 in Stage IV of patients showed more robust immune reactivity (P < 0.01) compare with normal serum.
Comparison of immune reactivity against lysates from SW48 versus SW1116 cells
The immune reactivity pattern of patients' sera (from different stages of CRC) with SW48 and SW1116 cell lysate were different [ Table 1 ]. However, it was similar for normal control sera, and no significant difference was seen, except for band 8 which had a higher intensity in SW48 cell lysate. Immune reactivity pattern between both Stage I and Stage II patients' sera with SW48 and SW1116 cell lines lysate showed that the only difference was in band 8 intensity. However, for both groups the band 8 Intensity related to SW48 cell lysate was higher than SW1116 that had the P < 0.05 and P = 0.01, respectively.
The most difference in immune reactivity pattern exists between SW48 and SW1116 cell line lysate in reaction with sera from Stage III CRC patients as the band intensity was extremely clear. Therefore, both bands 6 and 8 showed significant differences in intensity (P = 0.001) in both cell lines. Moreover, the intensity of bands 4, 5 and 7 related to SW48 cell lysate were higher than SW1116 cell lysate (P = 0.01) as well as the intensity of band 2 from SW48 cell lysate which was also significant (P < 0.05) in compared to SW1116 cell lysate. The immune reactivity pattern of Stage IV patients' sera with SW48 and SW1116 cell lysate also confirmed that from 10 bands only bands 7 and 8 were different among two cell lines. The mean intensity of band 7 and 8 in Stage IV patients' sera in reaction with SW48 cell lysate were significantly higher than that of SW1116 cell lysate (P < 0.05).
Comparing the immune reactivity of colorectal cancer patients' sera with SW48 and SW1116 versus MCF7, SKBR3, A549, MHR80, MIAPACA2 and PATU8902
The ImageJ software was used to elicit the signal intensities of each immunoblot page and generate a plot diagram. The Figure 4 : The mean intensities of 10 immune reactive bands relating to normal and four stages of colorectal cancer patients' sera reacted with SW48 cell lysate. According to the immunoblotting evaluation by ImageJ software 10 bands (that were common in all serum immune reactivity) were selected for calculating the mean intensity. Among these 10 reactive bands, 2, 4, 6, and 8 had a significantly higher intensity (P = 0.001) in Stage III patients' sera versus normal ones. Moreover, the most difference intensity was related to sera from patients with Stage III and normal ones Figure 5 : The mean intensities of 10 immune reactive bands relating to normal and four stages of colorectal cancer patients' sera reacted with SW1116 cell lysate. There was not any significant difference in immune reactivity pattern of normal and Stage I colorectal cancer patients' sera. Yet, there was a significant difference in the intensity of bands 2, 3 and 7 of sera from stage II colorectal cancer patients in reaction with SW1116 cell lysate versus normal sera (P < 0.01). Besides, the intensity of band 4 and 8 in Stage III and IV respectively showed significant differences in comparison with normal sera (P < 0.01)
